Table of Contents
<< Previous Issue | Jul 2021 (Vol: 2021, Issue: 7) | Next Issue >> |
- Section: Licensing
-
Novo Nordisk and Heartseed Enter into Agreement to Develop Cell therapy for Heart Failure
- Section: Mergers & Acquisitions
-
Danaher Continues Life Sciences Business Expansion with US$9.6 B Aldevron Acquisition
- Section: Research & Development
-
Zai Lab Forms Another Oncology Partnership with MacroGenics
-
Gilead’s Kite to Collaborate with Shoreline for CAR NK Therapies
-
iTeos Therapeutics signs US$2.75 B Agreement with GlaxoSmithKline
-
BMS Expands Oncology Portfolio with Eisai’s MORAb-202